MA32167B1 - Dérivés d'imidazo[1,2-b]pyridazine pour le traitement de maladies médiées par la tyrosine kinase c-met - Google Patents

Dérivés d'imidazo[1,2-b]pyridazine pour le traitement de maladies médiées par la tyrosine kinase c-met

Info

Publication number
MA32167B1
MA32167B1 MA33198A MA33198A MA32167B1 MA 32167 B1 MA32167 B1 MA 32167B1 MA 33198 A MA33198 A MA 33198A MA 33198 A MA33198 A MA 33198A MA 32167 B1 MA32167 B1 MA 32167B1
Authority
MA
Morocco
Prior art keywords
treatment
tyrosine kinase
imidazo
mediated diseases
kinase mediated
Prior art date
Application number
MA33198A
Other languages
Arabic (ar)
English (en)
Inventor
Pascal Furet
Clive Mccarthy
Joseph Schoepfer
Carsten Spanka
Melanie Stang
Frédéric Stauffer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39672115&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32167(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA32167B1 publication Critical patent/MA32167B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

La présente invention concerne des composés de formule (i) et des sels de ceux-ci, formule (i), dans lesquels les substituants sont comme défini dans la spécification, l'application d'un composé de formule (i) dans un procédé pour le traitement du corps humain ou animal, en particulier en ce qui concerne une maladie médiée par la tyrosine kinase c-met; l'utilisation d'un composé de formule (i) pour fabriquer un médicament pour le traitement de telles maladies; des compositions pharmaceutiques comprenant un composé de formule (i), facultativement en présence d'un partenaire de combinaison; des procédés pour la préparation d'un composé de formule (i).
MA33198A 2008-02-28 2010-09-24 Dérivés d'imidazo[1,2-b]pyridazine pour le traitement de maladies médiées par la tyrosine kinase c-met MA32167B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08152068 2008-02-28
PCT/EP2009/052302 WO2009106577A1 (fr) 2008-02-28 2009-02-26 Dérivés d’imidazo[1,2-b]pyridazine pour le traitement de maladies médiées par la tyrosine kinase c-met

Publications (1)

Publication Number Publication Date
MA32167B1 true MA32167B1 (fr) 2011-03-01

Family

ID=39672115

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33198A MA32167B1 (fr) 2008-02-28 2010-09-24 Dérivés d'imidazo[1,2-b]pyridazine pour le traitement de maladies médiées par la tyrosine kinase c-met

Country Status (25)

Country Link
US (1) US8822468B2 (fr)
EP (1) EP2265614A1 (fr)
JP (1) JP5576802B2 (fr)
KR (1) KR20100128305A (fr)
CN (1) CN102015716B (fr)
AR (1) AR070487A1 (fr)
AU (1) AU2009218459A1 (fr)
BR (1) BRPI0908504A2 (fr)
CA (1) CA2717034A1 (fr)
CL (1) CL2009000443A1 (fr)
CO (1) CO6300957A2 (fr)
CR (1) CR11620A (fr)
DO (1) DOP2010000263A (fr)
EA (1) EA201001365A1 (fr)
EC (1) ECSP10010427A (fr)
IL (1) IL207434A0 (fr)
MA (1) MA32167B1 (fr)
MX (1) MX2010009414A (fr)
NI (1) NI201000145A (fr)
PE (1) PE20091468A1 (fr)
SM (1) SMAP201000112A (fr)
TW (1) TW200940545A (fr)
UY (1) UY31676A1 (fr)
WO (1) WO2009106577A1 (fr)
ZA (1) ZA201005602B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY32049A (es) 2008-08-14 2010-03-26 Takeda Pharmaceutical Inhibidores de cmet
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
US8389526B2 (en) * 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
EA201200260A1 (ru) 2009-08-12 2012-09-28 Новартис Аг Гетероциклические гидразоны и их применение для лечения рака и воспаления
EA201200318A1 (ru) 2009-08-20 2012-09-28 Новартис Аг Гетероциклические оксимы
CN106432225B (zh) 2009-12-31 2019-02-19 和记黄埔医药（上海）有限公司 某些***并吡啶化合物和***并吡嗪化合物、其组合物和其使用方法
US20110195066A1 (en) * 2010-02-05 2011-08-11 Auspex Pharmaceuticals, Inc. Quinoline inhibitors of tyrosine kinase
WO2012003338A1 (fr) * 2010-07-01 2012-01-05 Takeda Pharmaceutical Company Limited Combinaison d'un inhibiteur de cmet et d'un anticorps dirigé contre hgf et/ou cmet
AR085183A1 (es) 2010-07-30 2013-09-18 Lilly Co Eli Compuesto 6-(1-metil-1h-pirazol-4-il)-3-(2-metil-2h-indazol-5-iltio)-[1,2,4]triazol[4,3-b]piridazina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar cancer
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
JP5944497B2 (ja) * 2011-06-22 2016-07-05 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ ヘテロシクリルアミノイミダゾピリダジン
CN103958509B (zh) * 2011-09-15 2015-12-23 诺华股份有限公司 作为酪氨酸激酶抑制剂的6-取代的3-(喹啉-6-基硫代)-[1,2,4]***并[4,3-a]吡啶化合物
MX339302B (es) 2011-09-15 2016-05-19 Novartis Ag 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina.
CN103122000B (zh) * 2012-09-03 2013-12-25 中美冠科生物技术（太仓）有限公司 用作抗肿瘤药物的高选择性的c-Met激酶抑制剂
PT2925757T (pt) 2012-11-19 2018-01-09 Novartis Ag Compostos e composições para o tratamento de doenças parasitárias
CN105431148A (zh) 2013-03-07 2016-03-23 加利菲亚生物公司 混合谱系激酶抑制剂及治疗方法
AR097543A1 (es) * 2013-09-06 2016-03-23 Lexicon Pharmaceuticals Inc COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
CN105326793A (zh) * 2014-08-06 2016-02-17 中美冠科生物技术（太仓）有限公司 一种包含c-Met激酶抑制剂的固体分散体及其制备方法和用途
AU2015366190B2 (en) * 2014-12-19 2020-01-23 Janssen Pharmaceutica Nv Imidazopyridazine derivatives as P13Kbeta inhibitors
CA2967546A1 (fr) * 2014-12-19 2016-06-23 Janssen Pharmaceutica Nv Derives d'imidazopyridazine a liaison heterocyclyle en tant qu'inhibiteurs pi3k.beta.
CN109715631B (zh) * 2016-09-16 2022-02-18 德国亥姆霍兹慕尼黑中心健康与环境研究中心（有限公司） Traf 6抑制剂
WO2018138050A1 (fr) 2017-01-26 2018-08-02 Bayer Aktiengesellschaft Dérivés hétérocycliques bicycliques condensés utilisés comme pesticides
US11584744B2 (en) * 2017-06-23 2023-02-21 University Of Washington Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them
EP4077332A4 (fr) * 2019-12-18 2024-05-01 Univ California Inhibiteurs de lin28 et leurs méthodes d'utilisation

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489755A (en) * 1966-08-03 1970-01-13 Pfizer & Co C Imidazo (1,2-b) pyridazines
GB8719368D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Heterocyclic compounds
FR2619818B1 (fr) * 1987-09-01 1990-01-12 Sanofi Sa Imidazo (1,2-b) pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
CA2057089A1 (fr) 1990-12-07 1992-06-08 Eric E. Allen Derives de substitution de pyrazolopyrimidines and d'imidazopyridazines, antagonistes de l'angiotensine ii
WO2001083481A1 (fr) 2000-04-27 2001-11-08 Yamanouchi Pharmaceutical Co., Ltd. Derives d'imidazopyridine
TWI312347B (en) * 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
EP1581526B1 (fr) 2002-12-18 2009-03-11 Vertex Pharmaceuticals Incorporated Derives de benzisoxazole utiles en tant qu'inhibiteurs des proteines kinases
CN1816528A (zh) 2003-06-30 2006-08-09 麦克公司 作为雄激素受体调节剂的17－乙酰氨基－4－氮杂甾类衍生物
US7037909B2 (en) 2003-07-02 2006-05-02 Sugen, Inc. Tetracyclic compounds as c-Met inhibitors
US7122548B2 (en) 2003-07-02 2006-10-17 Sugen, Inc. Triazolotriazine compounds and uses thereof
JP2007509150A (ja) 2003-10-21 2007-04-12 メルク　エンド　カムパニー　インコーポレーテッド 神経障害性疼痛の治療において有用なトリアゾロ−ピリダジン化合物および、この誘導体
WO2005051301A2 (fr) 2003-11-19 2005-06-09 Array Biopharma Inc. Inhibiteurs heterocycliques de mek et leurs procedes d'utilisation
WO2005073224A2 (fr) 2004-01-23 2005-08-11 Amgen Inc Composes et methodes d'utilisation de ces derniers
US20090023737A1 (en) 2004-02-12 2009-01-22 Neurogen Corporation Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor Ligands
US7456289B2 (en) * 2004-12-31 2008-11-25 National Health Research Institutes Anti-tumor compounds
RU2412943C2 (ru) * 2005-03-23 2011-02-27 Ф. Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ АЦЕТИЛЕНИЛ-ПИРАЗОЛО-ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2
CA2606017A1 (fr) 2005-05-12 2006-11-23 Merck & Co., Inc. Inhibiteurs de la tyrosine kinase
US20100216798A1 (en) * 2005-07-29 2010-08-26 Astellas Pharma Inc Fused heterocycles as lck inhibitors
US20070078136A1 (en) 2005-09-22 2007-04-05 Bristol-Myers Squibb Company Fused heterocyclic compounds useful as kinase modulators
CA2630884A1 (fr) 2005-11-30 2007-06-07 Vertex Pharmaceuticals Incorporated Inhibiteurs de c-met et leurs utilisations
US7348325B2 (en) * 2005-11-30 2008-03-25 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
EA015754B1 (ru) 2005-12-21 2011-12-30 Янссен Фармацевтика, Н.В. Триазолопиридазины в качестве модуляторов тирозинкиназы
NL2000613C2 (nl) * 2006-05-11 2007-11-20 Pfizer Prod Inc Triazoolpyrazinederivaten.
EP2032578A2 (fr) 2006-05-30 2009-03-11 Pfizer Products Incorporated Dérivés de la triazolopyridazine
US8198448B2 (en) * 2006-07-14 2012-06-12 Amgen Inc. Fused heterocyclic derivatives and methods of use
PE20080403A1 (es) * 2006-07-14 2008-04-25 Amgen Inc Derivados heterociclicos fusionados y metodos de uso
US8217177B2 (en) * 2006-07-14 2012-07-10 Amgen Inc. Fused heterocyclic derivatives and methods of use
MX2009001349A (es) 2006-08-04 2009-04-17 Takeda Pharmaceutical Derivado heterociclico fusionado y su uso.
WO2008021781A1 (fr) * 2006-08-07 2008-02-21 Incyte Corporation Utilisation de triazolotriazines en tant qu'inhibiteurs des kinases
US20100144738A1 (en) 2006-09-05 2010-06-10 William Bornmann Inhibitors of c-met and uses thereof
US20110021513A1 (en) 2006-09-07 2011-01-27 Biogen Idec Ma Inc. Modulators of interleukin-1 receptor-associated kinase
KR101083177B1 (ko) 2006-10-23 2011-11-11 에스지엑스 파마슈티컬스, 인코포레이티드 트리아졸로-피리다진 단백질 키나제 조정제
ES2689444T3 (es) 2006-11-22 2018-11-14 Incyte Holdings Corporation Imidazotriazinas e imidazopirimidinas como inhibidores de la quinasa
AR064420A1 (es) * 2006-12-21 2009-04-01 Alcon Mfg Ltd Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop).
WO2009011954A2 (fr) 2007-04-27 2009-01-22 Alaka'i Consulting & Engineering, Inc. Système de spectroscopie laser
EP2170894A1 (fr) 2007-06-21 2010-04-07 Janssen Pharmaceutica N.V. Formes polymorphes et hydratées, sels et procédé de préparation de la 6-{difluoro[6-(1-méthyl-1h-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]méthyl}quinoléine
US20110046127A1 (en) * 2007-11-08 2011-02-24 Paolo Pevarello Imidazopyridazines for Use as Protein Kinase Inhibitors
WO2009088955A2 (fr) 2007-12-31 2009-07-16 Energenox, Inc. Turbine à effet de couche limite
JP2009227599A (ja) 2008-03-21 2009-10-08 Daiichi Sankyo Co Ltd イミダゾピリダジン誘導体

Also Published As

Publication number Publication date
EA201001365A1 (ru) 2011-04-29
ZA201005602B (en) 2011-04-28
CN102015716A (zh) 2011-04-13
CR11620A (es) 2010-10-08
CO6300957A2 (es) 2011-07-21
MX2010009414A (es) 2010-09-24
DOP2010000263A (es) 2010-09-30
IL207434A0 (en) 2010-12-30
US8822468B2 (en) 2014-09-02
CN102015716B (zh) 2014-09-17
CL2009000443A1 (es) 2010-09-10
ECSP10010427A (es) 2010-09-30
JP5576802B2 (ja) 2014-08-20
PE20091468A1 (es) 2009-10-22
UY31676A1 (es) 2009-09-30
NI201000145A (es) 2011-03-02
SMAP201000112A (it) 2010-11-12
TW200940545A (en) 2009-10-01
KR20100128305A (ko) 2010-12-07
CA2717034A1 (fr) 2009-09-03
US20090264406A1 (en) 2009-10-22
EP2265614A1 (fr) 2010-12-29
JP2011513279A (ja) 2011-04-28
AU2009218459A1 (en) 2009-09-03
BRPI0908504A2 (pt) 2015-08-11
AR070487A1 (es) 2010-04-07
WO2009106577A1 (fr) 2009-09-03

Similar Documents

Publication Publication Date Title
MA32167B1 (fr) Dérivés d'imidazo[1,2-b]pyridazine pour le traitement de maladies médiées par la tyrosine kinase c-met
EA201000552A1 (ru) Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в
NO20063758L (no) Pyrazolo[1,5-A]pyrimidin-7-yl-amin derivater for anvendelse i behandling av proteinkinase avhengige sykdommer
ATE329596T1 (de) Phthalazinderivate zur behandlung von entzündlicher erkrankungen
WO2010066684A3 (fr) Inhibiteurs pyridyloxyindoles de vegf-r2 et utilisation thérapeutique de ceux-ci
ES2354824T3 (es) Pirazolo[1,5-a]pirimidinas útiles como inhibidores de proteínas cinasas.
EA200970611A1 (ru) Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
EA200900388A1 (ru) Бензоксазолы и оксазолопиридины, применимые в качестве ингибиторов киназ janus
EA201200318A1 (ru) Гетероциклические оксимы
BRPI0509069A (pt) compostos de imidazol para o tratamento de distúrbios neurodegenerativos
EA201200260A1 (ru) Гетероциклические гидразоны и их применение для лечения рака и воспаления
MY155565A (en) Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
EA200870373A1 (ru) Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ
TW200613305A (en) Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one
EA201070929A1 (ru) ФУРО- И ТИЕНО[3,2-c]ПИРИДИНЫ
EP1973407A4 (fr) Composes spiro et procedes d utilisation
ATE453646T1 (de) 3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
UA103617C2 (ru) Производные тиенопиридона как активаторы амр-активированной протеинкиназы (амрк)
EA201101704A1 (ru) ПРОИЗВОДНЫЕ 1H-ИМИДАЗО[4,5-c]ХИНОЛИНОНА
IL192557A (en) Imidazole derivatives are conserved and used as ptpase inhibitors
MX2012001529A (es) Derivados de 3-heteroaril-metil-imidazo-[1,2-b]-piridazin-6-ilo como moduladores de cinasa de tirosina c-met.
EA201490630A1 (ru) 6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы
UA95780C2 (en) Xanthine derivatives as selective hm74a agonists
EA200600318A1 (ru) ПРОИЗВОДНЫЕ 3-НИТРОПИРАЗОЛО[1,5-a]ПИРИМИДИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО (ВАРИАНТЫ) И СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ РЕЦЕПТОРА ГАМК(ВАРИАНТЫ)
UA100390C2 (en) Pyrrolo[2,3-d]pyrimidin derivatives as protein kinase b inhibitors